PROKARIUM LTD has a total of 11 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United Kingdom. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are MICROVAX LLC, NANTCELL INC and CANSINO BIOLOGICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | United Kingdom | 2 | |
#4 | United States | 2 | |
#5 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Climate change adaptation technologies | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Cranenburgh Rocky | 4 |
#2 | Cranenburgh Rocky Marc | 3 |
#3 | Soulier Annelise Juliette | 3 |
#4 | Ryan Aindrias | 2 |
#5 | Salerno Paola | 2 |
#6 | Moreira Ricardo Neves | 2 |
#7 | Telfer Jonathan Lewis | 2 |
#8 | Caproni Lisa | 1 |
#9 | Lacy Michael Joseph | 1 |
#10 | Redfern Mark Richard | 1 |
Publication | Filing date | Title |
---|---|---|
GB202102677D0 | Vaccine | |
GB202009413D0 | Spi-1 secretion systems | |
US2020237887A1 | Modified strain of Salmonella enterica Typhi | |
EP3495378A1 | Vaccine compositions | |
EP3495469A1 | Vaccine compositions ii | |
EP2326344A1 | Salmonella vectored vaccines against chlamydia and methods of use |